Creative Biolabs-Immuno-oncology

Anti-DR5 (clone TR2E.2E1G) SynExpress SP-BF-I4-E Modified CD8+ T cells (CAT#: ITS-1224-CR2292)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DR5 (clone TR2E.2E1G). We employs the pGEX (SP6-BFP-IL-4-EcoRI) vector components and the SynExpress system of the Single base pair Insertion/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DR5
Clone
TR2E.2E1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
SP6
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
Insertion
Modification Domain
Single base pair
Carrier Type
pGEX
Transformation Accuracy
0.89
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving